Founded 2007 by Jan Mikael Nordfors MD, only for informational purposes. Shall not replace the advice of a skilled therapist.
You are here
» Neuroendocrine Tumors
Items per page
Phase II study of RAD001 (everolimus) and depot octreotide (sandostatin LAR) in advanced low grade neuroendocrine carcinoma (LGN
Phase II trial of pharmacodynamically (PDally)-guided optimal biologic dose titration (OBDT) of sorafenib (S) in combination wit
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors.
The Mikael Nordfors site operates under a Creative Commons License
Copyright © 2020,